Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Dr Reddy's Laboratories-ADRRDY19.783.813.73-0.0120.59%3.35%37.47$78.85$172.1713,974$78.84

Detail of Dr Reddy's Laboratories-ADR

 
CEO
Mr. Erez Israeli M.B.A.
Employees
27048
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Market cap
$1,099B

Company details

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OTH
OI
OIE
PI
TAX
NI
Revenue (Rev)
$288.51B
Cost of goods (CoG)
-$118.11B
Gross profit (GP)
$170.40B
Operating expense (OE)
-$104.82B
Research and development (R&D)
-$24.08B
General and administrative (G&A)
-$82.19B
Other (OTH)
$1.46B
Operating income (OI)
$65.58B
Other income expense (OIE)
-$5.20B
Pretax income (PI)
$72.23B
Tax (TAX)
-$16.65B
Net income (NI)
$55.58B
Dr Reddy's Laboratories-ADR
RDY • XNYS • US
$78.84
+12.11 (18.15%)
Stock vs Industry average
  • Industry average

Dividend yield
0.61%
Trailing annual dividend rate
$40.00
Payout ratio
0.00%
EPS
$3.99
Margin profit
19.26%
52 week low
$64.269997
52 week high
$84.209999
50-day simple moving average
$78.73
200-day simple moving average
$78.85
Percent held by insiders
0.00%
Percent held by institutions
15.13%
Dividend yield
50.27%

Change of shares

Cash vs Debt

Comparison of selected companies

 
%
Price change
RDY +18.15%
eps change
RDY -0.96%